PSOC

1 clinical trials · Condition

Record	Firm	Date
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy (NCT07225270)	Genmab	2026-04-03

Every clearance here is in the API, with alerts when new ones post.